MeiraGTx Holdings

MGTX · NASDAQ

$9.97+$0.52 (+5.50%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $9.45

About MGTX

MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. The company has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. The company is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Employees: 400
Headquarters: New York City, New York
Listed: Jun 8, 2018
Sector: Health Care
Industry: Biotechnology
Website: meiragtx.com

Leadership

MeiraGTx Holdings executives
Name	Title	Since	Age
Keith Harris	—	—	72
Alexandria Forbes	—	2015	60
Richard Giroux	—	—	52
Robert Wollin	—	—	49
Stuart Naylor	—	2015	62
Robert Zeldin	—	—	62
Ellen Hukkelhoven	—	—	38
Lord Mendoza	—	—	65
Nicole Seligman	—	—	68
Thomas Shenk	—	—	78
Debra Yu	—	—	60

Revenue by product and region

Fiscal year ended Dec 31, 2025: $81.39M total revenue

By product

License [Member]$74.99M92.1%
Revenue from related parties earned for services rendered.$6.40M7.9%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

MeiraGTx Holdings suppliers and customers
Company	Relationship	Country	Correlation
Kadmon Holdings, Inc. KDMN	Supplier	US	-0.62
Johnson & Johnson JNJ	Supplier and customer	US	-0.71
Brandeis University	Supplier and customer	US	—
United States	Supplier and customer	US	—
Froedtert & the Medical College of Wisconsin	Supplier and customer	US	—
Massachusetts Eye & Ear Infirmary, Inc.	Supplier and customer	US	—
Oregon Health & Science University	Supplier and customer	US	—
University of Michigan	Supplier and customer	US	—
University College London	Supplier and customer	GB	—
United Kingdom	Supplier and customer	GB	—

Similar companies

Companies in the same industry as MeiraGTx Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.